Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on Nocturnal Hypertension: A Post Hoc Analysis of the ESAX-HTN Study.

Kazuomi KarioSadayoshi ItoHiroshi ItohHiromi RakugiYasuyuki OkudaMotonobu YoshimuraSatoru Yamakawa

Published in: American journal of hypertension (2021)

Esaxerenone may be an effective treatment option for nocturnal hypertension, especially in older patients and those with a non-dipper pattern of nocturnal BP.

Keyphrases

blood pressure
obstructive sleep apnea
sleep apnea
sleep quality
angiotensin converting enzyme
arterial hypertension
smoking cessation